Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI)

Details for Australian Patent Application No. 2002365131 (hide)

International Classifications

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 60/328,806 15.10.01 US

4 September 2003 Application Open to Public Inspection

Published as AU-B-2002365131

22 February 2007 Amendment Made

The nature of the amendment is: Amend the inventor name from Creasey, Alba A to Creasey, Abla A 2003

1 March 2007 Application Accepted

Published as AU-B-2002365131

6 September 2007 Standard Patent Sealed

27 November 2008 Alteration of Name

The name of the patentee has been altered to Novartis Vaccines and Diagnostics, Inc. 2003

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.